BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 9628099)

  • 1. Uveitis in leprosy patients who got inactive condition in pre-WHO/MDT era.
    Namisato N; Joko S; Izumi S; Murakai K; Ogawa H
    Lepr Rev; 1998 Mar; 69(1):82-6. PubMed ID: 9628099
    [No Abstract]   [Full Text] [Related]  

  • 2. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
    Gelber RH; Balagon VF; Cellona RV
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leprosy in The Netherlands in the period 1970-1991].
    Post E; chin-A-Lien RA; Bouman C; Naafs B; Faber WR
    Ned Tijdschr Geneeskd; 1994 Sep; 138(39):1960-3. PubMed ID: 7935946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic characteristics of leprosy reactions.
    Scollard DM; Smith T; Bhoopat L; Theetranont C; Rangdaeng S; Morens DM
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):559-67. PubMed ID: 7868954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audiovestibular involvement in leprosy.
    Awasthi SK; Singh G; Dutta RK; Pahuja OP
    Indian J Lepr; 1990; 62(4):429-34. PubMed ID: 2086677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):436-44. PubMed ID: 1474282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical and morphological study of amyloidosis complicating leprosy in Malaysian patients.
    Looi LM; Jayalakshim P; Lim KJ; Rajagopalan K
    Ann Acad Med Singap; 1988 Oct; 17(4):573-8. PubMed ID: 3223746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of acral bone resorption in multibacillary leprosy.
    Illarramendi X; Carregal E; Nery JA; Sarno EN
    Acta Leprol; 2000-2001; 12(1):29-37. PubMed ID: 11526639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy among inmates of a prison.
    Vijayakumaran P; Manimozhi N; Ravikumar RN; Jesudasan K; Rao PS
    Indian J Lepr; 1996; 68(3):247-50. PubMed ID: 8889610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and skin lesion cytokine profile in Brazilian patients with borderline tuberculoid and borderline lepromatous leprosy.
    Venturini J; Soares CT; Belone Ade F; Barreto JA; Ura S; Lauris JR; Vilani-Moreno FR
    Lepr Rev; 2011 Mar; 82(1):25-35. PubMed ID: 21644469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy in five human immunodeficiency virus-infected patients.
    Moran CA; Nelson AM; Tuur SM; Luengu M; Fonseca L; Meyers WM
    Mod Pathol; 1995 Aug; 8(6):662-4. PubMed ID: 8532702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy in low endemic areas of India: an appraisal and suggested measures for control.
    Misra RS; Ramesh V; Nigam PK
    Indian J Lepr; 1989 Jul; 61(3):345-50. PubMed ID: 2768882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of MDT on leprosy as measured by selective indicators.
    Jesudasan K; Vijayakumaran P; Pannikar VK; Christian M
    Lepr Rev; 1988 Sep; 59(3):215-23. PubMed ID: 3264374
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leprosy simulating other diseases].
    López-Vélez R; Sáez Vaquero T; Blanco Arévalo JL; Gómez Mampaso E
    Rev Clin Esp; 1999 Jun; 199(6):369-72. PubMed ID: 10432812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of incidence of Australia antigen and derangements in liver function tests in leprosy.
    Nayak KC; Gupta RK; Aggarwal TD; Chadda VS; Kumar KK
    Indian J Lepr; 1989 Jan; 61(1):23-30. PubMed ID: 2703743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve damage in leprosy.
    Job CK
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):532-9. PubMed ID: 2545801
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leprosy - An overview from a pediatric perspective].
    Magdorf K; Haas WH; Harms D; Höger PH; Griese M; Rank M
    Klin Padiatr; 2001; 213(5):266-70. PubMed ID: 11582524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.